
AI-based postoperative wound monitoring technology that assesses wound health status, patient medication adherence, and patient vital signs to predict wound healing outcomes.

AI-based postoperative wound monitoring technology that assesses wound health status, patient medication adherence, and patient vital signs to predict wound healing outcomes.
Product: MyHealthPal — AI-based postoperative wound monitoring and SSI risk prediction
Regulatory status: FDA-listed as a Class I medical device
Founded / HQ: Founded 2021; Boston/Bedford, Massachusetts area
Employee count: Approximately 14 employees
Postoperative wound monitoring and surgical site infection prediction
2021
Digital health / Medtech
Total Funding: 0.00 USD